Effect of belimumab in patients with systemic lupus erythematosus treated with low dose or no corticosteroids
Yeo-Jin Lee, Soo Min Ahn, Seokchan Hong, Ji-Seon Oh, Chang-Keun Lee, Bin Yoo, Yong-Gil Kim
Korean J Intern Med. 2024;39(2):338-346. Published online 2023 Nov 30 DOI: https://doi.org/10.3904/kjim.2023.229
Citations to this article as recorded by 
Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort
Greta Hulej, Federico Arru, Benedetta Bianchi, Alessandra Bortoluzzi, Luisa Brussino, Paola Castrignanò, Alberto Cauli, Lorenzo Cavagna, Elisabetta Chessa, Emanuele Chiara, Rossella De Angelis, Ginevra De Marchi, Roberto Depascale, Marco Di Carlo, Giacomo
Lupus Science & Medicine.2026; 13(1): e001934. CrossRef
Therapeutic potential of CD20/CD3 bispecific antibodies in the treatment of autoimmune diseases
Hongpeng Huang, Xuetao Wei
Rheumatology and Immunology Research.2025; 5(4): 209. CrossRef
Soluble checkpoint molecules as predictive biomarker for disease activity and long-term outcome in SLE
Léa-Sophie Dreveton, Jakob Joachim Spencker, Hector Rincon-Arevalo, Arman Aue, Bilgin Osmanodja, Annika Wiedemann, Franziska Szelinski, Gerhard Krönke, Thomas Dörner, Eva Schrezenmeier, Ana-Luisa Stefanski
Frontiers in Immunology.2025;[Epub] CrossRef